About Rexcin Pharmaceuticals Private Limited
Data last updated:
Rexcin Pharmaceuticals Private Limited is a private limited company based in New, Delhi, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 16 December 2003 and has been in existence for over 23 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24239DL2003PTC123544. Its GSTIN is 07AACCR6446C1ZJ (Delhi). The company holds 4 GST registrations, of which 3 are active.
The company has an authorised share capital of ₹28 Lakh and a paid-up capital of ₹2 Lakh. It is led by directors Satinder Pal Singh and Pradeep Saxena.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Flat No. 17 – B First Floor Block A – 1A Janakpuri, New, Delhi, India – 110058.
As per the financials filed for FY 2025, the company reported a revenue of ₹8.57 Cr, a growth of 15% compared to the previous year. For the same year it recorded a net profit of ₹2.05 Cr (net margin 23.8%) and EBITDA of ₹2.81 Cr (EBITDA margin 32.8%). Revenue has declined at a compounded annual rate (CAGR) of 3% over three years and 8% over five years.
The company has about 1 employee on its provident fund (EPFO) records. Its group structure includes 1 subsidiary.
The company is associated with 1 brand: Rexcin Pharmaceuticals. Court records list 58 cases involving the company, including 55 filed by the company and 3 filed against it; 23 cases are pending.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website rexcinpharma.com.
- EmailLocked
- TelephoneLocked
- Website
- Social Media
- Registered AddressFlat No. 17 – B First Floor Block A – 1A Janakpuri, New, Delhi, India – 110058
- IndustryPharma, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Rexcin Pharmaceuticals Private Limited
The main business activities of Rexcin Pharmaceuticals are manufacturing and trade. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products and wholesale trading. 2 activity segments are registered with the MCA.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | Locked |
| G | Trade | G1 | Wholesale Trading | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Rexcin Pharmaceuticals Private Limited FY 2025 filings available
Rexcin Pharmaceuticals Private Limited reported revenue of ₹8.57 Cr (up 15% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Rexcin Pharmaceuticals Private Limited
Revenue rose 15% in the latest year, though over five years it has declined at a compounded annual rate (CAGR) of 8%. EBITDA rose 35% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Rexcin Pharmaceuticals Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹2.81 Cr | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹2.05 Cr | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Rexcin Pharmaceuticals Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 32.8% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 23.8% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Rexcin Pharmaceuticals are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Rexcin Pharmaceuticals Private Limited
Rexcin Pharmaceuticals Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Formulations, Pharmaceuticals). Revenue, net profit, margin and growth of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Rebase Lifescience Private Limited | •••• | •••• | •••• | •••• | - | Lalpur, Gujarat, India |
| Nivaara Chemicals Private Limited | •••• | •••• | •••• | •••• | - | Bhiwandi, Maharashtra, India |
| Maxamus Pharma Private Limited | •••• | •••• | •••• | •••• | 59 | New Delhi, Delhi, India |
| Qpharm Health Care Limited | •••• | •••• | •••• | •••• | 31 | Jaipur, Rajasthan, India |
| Modasa Pharmaceuticals Private Limited | •••• | •••• | •••• | •••• | - | Modasa, Gujarat, India |
| Rexcin Pharmaceuticals Private Limited this company | •••• | •••• | •••• | •••• | - | New Delhi, Delhi, India |
| Lutim Pharma Private Limited | •••• | •••• | •••• | •••• | 26 | Dehradun, Uttarakhand, India |
| Heal (India) Laboratories Private Limited | •••• | •••• | •••• | •••• | - | Thiruvellor District, Tamil Nadu, India |
| Indeus Life Sciences Private Limited | •••• | •••• | •••• | •••• | 37 | Mumbai, Maharashtra, India |
| Medrhans Pharmaceuticals Private Limited | •••• | •••• | •••• | •••• | 46 | Hyderabad, Telangana, India |
| Swasthya Healthcare Private Limited | •••• | •••• | •••• | •••• | - | Thane, Maharashtra, India |
Peers are the five companies nearest above and the five nearest below Rexcin Pharmaceuticals by revenue in the Pharma industry (Formulations, Pharmaceuticals), from the latest filed financials of each company. Revenue, net profit, margin and growth of each peer are in the company report.
Auditor Details of Rexcin Pharmaceuticals Private Limited
Rexcin Pharmaceuticals Private Limited is audited by M S SEKHON & CO for the financial year 2019.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| M S SEKHON & CO | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Rexcin Pharmaceuticals Private Limited
Rexcin Pharmaceuticals has 2 current directors and 15 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Satinder Pal Singh | Director | 15 Jul 2015 | 11 Years 2 Months | Current |
| Pradeep Saxena | Director | 31 Jul 2013 | 13 Years 2 Months | Current |
Ownership and Shareholding of Rexcin Pharmaceuticals Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Rexcin Pharmaceuticals Private Limited
Rexcin Pharmaceuticals Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Legal Cases of Rexcin Pharmaceuticals Private Limited
Rexcin Pharmaceuticals Private Limited has 58 court cases on record: 55 filed by Rexcin Pharmaceuticals, 3 filed against it. 23 cases are pending and 35 are disposed. Status as checked between 21 Sep 2026 and 03 Oct 2026.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 57 | 2 | 23 |
| District courts | 1 | 1 | 0 |
Cases on record (5 of 58)
| Court | Type of case | Party | Status |
|---|---|---|---|
| High Court of Delhi | Commercial suit | Filed against the company by Rekin Pharma Private Limited | Disposed |
| High Court of Delhi | Court case (C.O. (COMM.IPD-TM)) | Filed by the company against Rekin Pharma Private Limited | Disposed |
| High Court of Delhi | Commercial suit | Filed by the company against Rekin Pharma Private Limited | Disposed |
| District court, South West, Delhi | Court case (CS DJ ADJ) | Filed against the company by Rekin Pharma Private Limited | Disposed |
| High Court of Delhi | Court case (CS(OS)) | Filed by the company against Alto Healthcare Private Limited | Disposed |
Full case history
All 58 cases with case numbers, court, year-wise trend, opposite parties and decision dates are in the company report.
- Every case with its case number
- Year-wise trend
- Opposite parties
- Decision dates and orders
Verified entity values are shown only after access is granted.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Associated Brands with Rexcin Pharmaceuticals Private Limited
Rexcin Pharmaceuticals operates one associated brand: Rexcin Pharmaceuticals. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Manufactures and markets dermatological pharmaceutical products. | rexcinpharma.com |
Employees and EPFO Compliance at Rexcin Pharmaceuticals Private Limited
Rexcin Pharmaceuticals Private Limited has a workforce of 1 employees as of Apr 08, 2024.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Group Structure of Rexcin Pharmaceuticals Private Limited
Rexcin Pharmaceuticals has 1 subsidiary company and 2 associated companies. This group structure data is as of FY 2019. The table lists each entity with its relationship and holding.
| Company Name | CIN | Shares Held |
|---|---|---|
| Best Laboratories Private Limited | U74999DL2003PTC123593 | Locked |
Showing major subsidiaries. Total: 1.
Recent Activity on Rexcin Pharmaceuticals Private Limited
Rexcin Pharmaceuticals Private Limited has 17 board changes on record since 2007: 2 appointments and 15 cessations. The latest: Digvijay Singh Chauhan ceased to be Additional Director on 02 Dec 2015.
8 earlier events are listed in the company report.
Credit Ratings, Litigation & Regulatory Alerts for Rexcin Pharmaceuticals Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Rexcin Pharmaceuticals Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Rexcin Pharmaceuticals Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Rexcin Pharmaceuticals Private Limited
Rexcin Pharmaceuticals has 4 GST registrations: 3 active and 1 cancelled or inactive.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07AACCR6446C1ZJ | Delhi | Active | 01 Jul 2017 |
| 02AACCR6446C1ZT | Himachal Pradesh | Active | 01 Jul 2017 |
| 23AACCR6446C1ZP | Madhya Pradesh | Active | 01 Jul 2017 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Rexcin Pharmaceuticals Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Rexcin Pharmaceuticals Private Limited
Rexcin Pharmaceuticals is an active private limited company based in New, Delhi, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 16 December 2003 (23+ years old) and is registered under CIN U24239DL2003PTC123544.
Rexcin Pharmaceuticals reported revenue of ₹8.57 Cr for FY 2025 (up 15% YoY).
Rexcin Pharmaceuticals has 2 current directors:
- Satinder Pal Singh - Director
- Pradeep Saxena - Director
Rexcin Pharmaceuticals reported a net profit of ₹2.05 Cr (net margin 23.8%) and EBITDA of ₹2.81 Cr (EBITDA margin 32.8%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Rexcin Pharmaceuticals is -3% over three years and -8% over five years. In the latest year (FY 2025) revenue rose 15%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Rexcin Pharmaceuticals is 07AACCR6446C1ZJ, registered in Delhi. The company has 4 GST registrations in all, of which 3 are active and 1 is cancelled or inactive. Other active GSTINs include 02AACCR6446C1ZT (Himachal Pradesh), 23AACCR6446C1ZP (Madhya Pradesh).
The CIN (Corporate Identification Number) of Rexcin Pharmaceuticals is U24239DL2003PTC123544. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Rexcin Pharmaceuticals has 58 court cases on record: 55 filed by the company and 3 filed against it. 23 are pending. Most are in the high courts.
Rexcin Pharmaceuticals was incorporated on 16 December 2003, making it 23+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Rexcin Pharmaceuticals by revenue are Rebase Lifescience Private Limited, Nivaara Chemicals Private Limited, Maxamus Pharma Private Limited, Qpharm Health Care Limited, Modasa Pharmaceuticals Private Limited and 5 more, all in the Pharma industry (Formulations, Pharmaceuticals).
Digvijay Singh Chauhan ceased to be Additional Director on 02 Dec 2015. Satinder Pal Singh ceased to be Additional Director on 30 Sep 2015. Satinder Pal Singh was appointed as Director on 15 Jul 2015. Rexcin Pharmaceuticals has 17 board changes on record in total.